PolyPeptide Group AG (PPGN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 44.15 |
|---|---|
| 52-week range | 21.80 – 50.10 |
| Return, 1 month / 3 months | +0.1% / +0.9% |
| Return, 1 year / 3 years | +78.4% / +166.6% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 44.2% |
| Worst drawdown (1 year) | -24.4% |
| Average daily value traded | 4.73M CHF |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PolyPeptide Group makes peptide-based active pharmaceutical ingredients for the pharmaceutical and biotechnology industries. The company produces custom and generic peptides used in medicines, serving drug developers that need these compounds for their products. It also offers related services around peptide manufacturing and development. PolyPeptide Group is based in Switzerland and runs production facilities in Europe and the United States, supplying customers in the healthcare sector.
PolyPeptide Group AG trades under the code PPGN on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PolyPeptide Group AG (PPGN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 44.15 on 22 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 55 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 78.4% and over the last three months it rose 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.0% | ||
| From 52-week high | -10.6% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 0.9% | ||
| 6-month return | 27.2% | ||
| 12-month return, skipping the last month | 78.2% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.4% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.73M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | +0.1% |
| 3 months | +0.9% |
| 6 months | +27.2% |
| 1 year | +78.4% |
| 3 years | +166.6% |
| 5 years | −63.1% |
Signals
| 50-day / 200-day average | 44.03 / 37.09 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Apr 2022 | CHF 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.